CymitQuimica logo

CAS 630-56-8

:

Hydroxyprogesterone caproate

Description:
Hydroxyprogesterone caproate is a synthetic progestin, primarily used in hormone replacement therapy and to prevent preterm birth in certain high-risk pregnancies. It is a derivative of progesterone, characterized by the addition of a caproate ester group, which enhances its lipid solubility and prolongs its action in the body. The substance appears as a white to off-white crystalline powder and is typically administered via intramuscular injection. Hydroxyprogesterone caproate functions by modulating the effects of estrogen and progesterone in the body, thereby influencing various physiological processes, including the menstrual cycle and pregnancy maintenance. Its pharmacokinetics involve a gradual release into the bloodstream, allowing for sustained therapeutic effects. Common side effects may include injection site reactions, headaches, and mood changes, while more serious risks can involve thromboembolic events. As with any hormonal treatment, it is essential to use hydroxyprogesterone caproate under medical supervision to monitor for potential adverse effects and ensure appropriate dosing.
Formula:C27H40O4
InChI:InChI=1S/C27H40O4/c1-5-6-7-8-24(30)31-27(18(2)28)16-13-23-21-10-9-19-17-20(29)11-14-25(19,3)22(21)12-15-26(23,27)4/h17,21-23H,5-16H2,1-4H3/t21-,22+,23+,25+,26+,27+/m1/s1
InChI key:InChIKey=DOMWKUIIPQCAJU-LJHIYBGHSA-N
SMILES:O(C(CCCCC)=O)[C@@]1(C(C)=O)[C@]2(C)[C@@](CC1)([C@]3([C@](CC2)([C@]4(C)C(CC3)=CC(=O)CC4)[H])[H])[H]
Synonyms:
  • (8Xi,10Xi,13Xi)-3,20-Dioxopregn-4-En-17-Yl Hexanoate
  • (8Xi,9Xi,14Xi)-3,20-Dioxopregn-4-En-17-Yl Hexanoate
  • 17-Caproxyprogesterone
  • 17-[(1-Oxohexyl)oxy]pregn-4-ene-3,20-dione
  • 17A-Hydroxyprogesterone Caproate
  • 17alpha-Hydroxyprogesterone caproate
  • 17α-Caproyloxy-P4
  • 17α-Caproyloxypregn-4-ene-3,20-dione
  • 17α-Caproyloxyprogesterone
  • 17α-Hydroxypregn-4-ene-3,20-dione caproate
  • See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 18 products.